Patients: Trust and transparency key to using social media, apps to gather data

Members of an FDA committee agreed that social media and digital technologies could help companies and the agency gather real-world data on adverse events and patient-reported outcomes, but the parties must be transparent in the intended use of the data and share outcomes with patients.

The Thursday meeting of the Patient Engagement Advisory

Read the full 520 word article

User Sign In